Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study. (2009)

First Author: Ciceri F
Attributed to:  Expansion of the GMP facility for Stem Cell Therapy at Imperial College funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1470-2045(09)70074-9

PubMed Identifier: 19345145

Publication URI: http://europepmc.org/abstract/MED/19345145

Type: Journal Article/Review

Volume: 10

Parent Publication: The Lancet. Oncology

Issue: 5

ISSN: 1470-2045